Are we there yet? A machine learning architecture to predict organotropic metastases
Abstract Background & Aims Cancer metastasis into distant organs is an evolutionarily selective process. A better understanding of the driving forces endowing proliferative plasticity of tumor seeds in distant soils is required to develop and adapt better treatment systems for this lethal stage...
Main Authors: | Michael Skaro, Marcus Hill, Yi Zhou, Shannon Quinn, Melissa B. Davis, Andrea Sboner, Mandi Murph, Jonathan Arnold |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-11-01
|
Series: | BMC Medical Genomics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12920-021-01122-7 |
Similar Items
-
Heterogeneity of BCSCs contributes to the metastatic organotropism of breast cancer
by: Cenzhu Wang, et al.
Published: (2021-11-01) -
Subsite‐specific metastatic organotropism and risk in gastric cancer: A population‐based cohort study of the US SEER database and a Chinese single‐institutional registry
by: Ling Wang, et al.
Published: (2023-10-01) -
The metabolic adaptation mechanism of metastatic organotropism
by: Chao Wang, et al.
Published: (2021-04-01) -
Exosomal MicroRNAs and Organotropism in Breast Cancer Metastasis
by: Grace L. Wong, et al.
Published: (2020-07-01) -
Cell Cytoskeleton and Stiffness Are Mechanical Indicators of Organotropism in Breast Cancer
by: Kai Tang, et al.
Published: (2021-03-01)